These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 200571)
1. Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines. Nilsson K; Andersson LC; Gahmberg CG; Wigzell H Int J Cancer; 1977 Nov; 20(5):708-16. PubMed ID: 200571 [No Abstract] [Full Text] [Related]
2. Surface glycoprotein patterns of normal and malignant human lymphoid cells. I. T cells T blasts and leukemic T cell lines. Andersson LC; Gahmberg CG; Nilsson K; Wigzell H Int J Cancer; 1977 Nov; 20(5):702-7. PubMed ID: 303621 [TBL] [Abstract][Full Text] [Related]
3. Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines. Tatsumi E; Harada S; Kuszynski C; Volsky D; Minowada J; Purtilo DT Leuk Res; 1985; 9(2):231-8. PubMed ID: 2985880 [TBL] [Abstract][Full Text] [Related]
4. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. Yokochi T; Holly RD; Clark EA J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961 [TBL] [Abstract][Full Text] [Related]
5. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. Klein G; Ehlin-Henriksson B; Schlossman SF J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235 [TBL] [Abstract][Full Text] [Related]
6. Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines. van Beek WP; Nilsson K; Klein G; Emmelot P Int J Cancer; 1979 Apr; 23(4):464-73. PubMed ID: 220199 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of normal lymphocytes with autologous lymphoid cell lines: properties of derived killer cells. Svedmyr E; Jondal M; Leibold W Scand J Immunol; 1975; 4(7):721-34. PubMed ID: 173017 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Klein G; Dombos L; Gothoskar B Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458 [No Abstract] [Full Text] [Related]
10. Human B-lymphoid cell lines. Nilsson K Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931 [TBL] [Abstract][Full Text] [Related]
11. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias. Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966 [TBL] [Abstract][Full Text] [Related]
13. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay. Brown TD; Ernberg I; Lamon EW; Klein G Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574 [No Abstract] [Full Text] [Related]
14. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma. Klein G; Hyman R; Trowbridge I Int J Cancer; 1979 Jan; 23(1):37-41. PubMed ID: 215562 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Menezes J; Leibold W; Klein G; Clements G Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629 [TBL] [Abstract][Full Text] [Related]
16. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
17. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. McConnell I; Klein G; Lint TF; Lachmann PJ Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040 [TBL] [Abstract][Full Text] [Related]